These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 37340519)

  • 21. Feasibility of population-based screening of sickle cell disease through the primary health care system in tribal areas of India.
    Babu BV; Sharma Y; Sridevi P; Surti SB; Ranjit M; Bhat D; Sarmah J; Sudhakar G
    J Med Screen; 2023 Mar; 30(1):28-35. PubMed ID: 36036388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strengthening Health System and Community Mobilization for Sickle Cell Disease Screening and Management among Tribal Populations in India: An Interventional Study.
    Babu BV; Sharma Y; Sridevi P; Surti SB; Bhat D; Ranjit M; Sudhakar G; Sarmah J
    Hemoglobin; 2023 Nov; 47(6):227-236. PubMed ID: 38189147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sickle cell disease treatment and management in India: a systematic review of interventional studies.
    Sridevi P; Sharma Y; Balakrishna SL; Babu BV
    Trans R Soc Trop Med Hyg; 2022 Dec; 116(12):1101-1111. PubMed ID: 36227060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive integrated care for patients with sickle cell disease in a remote aboriginal tribal population in southern India.
    Nimgaonkar V; Krishnamurti L; Prabhakar H; Menon N
    Pediatr Blood Cancer; 2014 Apr; 61(4):702-5. PubMed ID: 24347362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indian sickle cell disease registry for surveillance and patient management: Development and implementation.
    Babu BV; Sharma Y; Surti SB; Bhat D; Sridevi P; Ranjit M; Sudhakar G; Sarmah J
    Int J Health Plann Manage; 2023 Sep; 38(5):1483-1494. PubMed ID: 37340519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sickle cell anemia/sickle cell disease and pregnancy outcomes among ethnic tribes in India: an integrative mini-review.
    Ganesh B; Rajakumar T; Acharya SK; Kaur H
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):4897-4904. PubMed ID: 33563075
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical manifestations of sickle cell disease in India: misconceptions and reality.
    Jain D; Mohanty D
    Curr Opin Hematol; 2018 May; 25(3):171-176. PubMed ID: 29465435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sickle cell disease in India.
    Colah R; Mukherjee M; Ghosh K
    Curr Opin Hematol; 2014 May; 21(3):215-23. PubMed ID: 24714525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Newborn Screening for Sickle Cell Disease: Indian Experience.
    Colah RB; Mehta P; Mukherjee MB
    Int J Neonatal Screen; 2018 Dec; 4(4):31. PubMed ID: 33072952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sickle cell disease in India: a scoping review from a health systems perspective to identify an agenda for research and action.
    Raman V; Seshadri T; Joice SV; N Srinivas P
    BMJ Glob Health; 2021 Feb; 6(2):. PubMed ID: 33602689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folate supplementation in people with sickle cell disease.
    Dixit R; Nettem S; Madan SS; Soe HHK; Abas AB; Vance LD; Stover PJ
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011130. PubMed ID: 29546732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sickle cell disease: current activities, public health implications, and future directions.
    Creary M; Williamson D; Kulkarni R
    J Womens Health (Larchmt); 2007 Jun; 16(5):575-82. PubMed ID: 17627395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comprehensive review of diverse issues related to sickle cell disease.
    Nikhar HS; Meshram SU; Shinde GB
    East Afr J Public Health; 2011 Jun; 8(2):164-9. PubMed ID: 22066306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sickle cell disease in Africa: an overview of the integrated approach to health, research, education and advocacy in Tanzania, 2004-2016.
    Tluway F; Makani J
    Br J Haematol; 2017 Jun; 177(6):919-929. PubMed ID: 28295224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
    Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
    JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolving locally appropriate models of care for indian sickle cell disease.
    Serjeant GR
    Indian J Med Res; 2016 Apr; 143(4):405-13. PubMed ID: 27377495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current perspectives of sickle cell disease in Nigeria: changing the narratives.
    Ojewunmi OO; Adeyemo TA; Ayinde OC; Iwalokun B; Adekile A
    Expert Rev Hematol; 2019 Aug; 12(8):609-620. PubMed ID: 31195888
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.